n.a. (TKMR)

4.02
0.08 1.95
NASDAQ
Prev Close 4.10
Open 4.22
Day Low/High 3.98 / 4.33
52 Wk Low/High 4.01 / 26.73
Volume 346.21K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)
Tekmira Provides Update On TKM-Ebola Phase I Clinical Hold

Tekmira Provides Update On TKM-Ebola Phase I Clinical Hold

All Other Clinical Development Programs On Track

Tekmira Pharmaceuticals is Now Oversold (TKMR)

Tekmira Pharmaceuticals is Now Oversold (TKMR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Why Tekmira Pharmaceuticals (TKMR) Stock Is Plunging Today

Why Tekmira Pharmaceuticals (TKMR) Stock Is Plunging Today

Tekmira Pharmaceuticals (TKMR) plunged Thursday after the company announced it had received verbal notice from the FDA of a clinical hold on the company's TKM-Ebola Phase I clinical trial.

First Week of TKMR December 20th Options Trading

First Week of TKMR December 20th Options Trading

Investors in Tekmira Pharmaceuticals Corp saw new options begin trading this week, for the December 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 212 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Tekmira Presents Positive Interim Results On Phase I/II Clinical Programs

Tekmira Presents Positive Interim Results On Phase I/II Clinical Programs

Confirms Safety Profile of Third Generation LNP

Tekmira Provides Corporate Update And Announces First Quarter 2014 Results

Tekmira Provides Corporate Update And Announces First Quarter 2014 Results

Conference Call at 4:30 pm Eastern Time Today

Relative Strength Alert For Tekmira Pharmaceuticals

Relative Strength Alert For Tekmira Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tekmira's Partner Presents New Clinical Data For LNP-Enabled Patisiran (ALN-TTR02)

Tekmira's Partner Presents New Clinical Data For LNP-Enabled Patisiran (ALN-TTR02)

Tekmira's LNP Technology Further Validated With New Results

Today's Dead Cat Bounce Stock Is Tekmira Pharmaceuticals Corporation (TKMR)

Today's Dead Cat Bounce Stock Is Tekmira Pharmaceuticals Corporation (TKMR)

Trade-Ideas LLC identified Tekmira Pharmaceuticals Corporation (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate

Why Tekmira Pharmaceuticals (TKMR) Stock Is Down Today

Why Tekmira Pharmaceuticals (TKMR) Stock Is Down Today

Tekmira Pharmaceuticals (TKMR) plunged Monday amid reports that Novartis (NVS) is closing a significant portion of its RNAi research endeavors in Boston. FierceBiotech reported the pharmaceutical giant's confirmation that ongoing problems in delivering such therapies tied to the limited number of potential relevant targets led to the move. "We have decided to significantly reduce our internal drug discovery efforts in RNA therapeutics," Novartis told FierceBiotech in a statement. "This decision was driven by ongoing challenges with formulation and delivery and the reality that the current range of medically relevant targets where siRNA may be used is quite narrow. In the future we will have a small group working in this field and look for partnering opportunities." Tekmira suffered in the wake of the news, as it is involved in RNAi drug development. The stock plunged more than 18% to hit a low of $15.02 for the day as of 3:03 p.m. on Monday.

Tekmira Pharmaceuticals Corporation Stock Downgraded (TKMR)

Tekmira Pharmaceuticals Corporation Stock Downgraded (TKMR)

Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) has been downgraded by TheStreet Ratings from from a hold to sell.

Ratings Changes Today

Upgrades: EE, TRLA Downgrades: TKMR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Tekmira Presents Advances In Anti-Viral Product Platform At Scientific Symposium

Tekmira Presents Advances In Anti-Viral Product Platform At Scientific Symposium

Preclinical Results Demonstrate Survival Following Lethal Marburg Infection When Treatment is Delayed 72 Hours

First Week of May 17th Options Trading For Tekmira Pharmaceuticals (TKMR)

First Week of May 17th Options Trading For Tekmira Pharmaceuticals (TKMR)

Investors in Tekmira Pharmaceuticals Corp saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

Tekmira Pharmaceuticals Corporation (TKMR) Moving On Heavy Volume In The Pre-Market Hours

Tekmira Pharmaceuticals Corporation (TKMR) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Tekmira Pharmaceuticals Corporation (TKMR) as a pre-market mover with heavy volume candidate

Up in smoke: Why I sold my marijuana stocks

Up in smoke: Why I sold my marijuana stocks

I've liquidated all my holdings in marijuana stocks for now.

Tekmira Provides Corporate Update And Announces Year-End 2013 Results

Tekmira Provides Corporate Update And Announces Year-End 2013 Results

Conference Call at 4:30 pm Eastern Time Today

Biotech Sector Performance February 2014: Red Hot But...

Biotech Sector Performance February 2014: Red Hot But...

An epic month of biotech stock performance ends with a significant sell off.

First Week of TKMR April 19th Options Trading

First Week of TKMR April 19th Options Trading

Investors in Tekmira Pharmaceuticals Corp saw new options begin trading this week, for the April 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new April 19th contracts and identified one put and one call contract of particular interest.

Tekmira Pharmaceuticals Corporation (TKMR) Highlighted As Today's Perilous Reversal Stock

Tekmira Pharmaceuticals Corporation (TKMR) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals Corporation (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate